519
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Acute exercise in elite rugby players increases the circulating level of the cardiovascular biomarker GDF-15

, , , , , , & show all
Pages 492-499 | Received 21 Oct 2013, Accepted 02 Feb 2014, Published online: 05 May 2014

References

  • Brancaccio P, Lippi G, Maffulli N. Biochemical markers of muscular damage. Clin Chem Lab Med 2010;48:757–67.
  • Eijsvogels TM, Shave R, van Dijk A, Hopman MT, Thijssen DH. Exercise-induced cardiac troponin release: real-life clinical confusion. Curr Med Chem 2011; 18:3457–61.
  • Lippi G, Schena F, Montagnana M, Salvagno GL, Banfi G, Guidi GC. Significant variation of traditional markers of liver injury after a half-marathon run. Eur J Intern Med 2011;22:36–8.
  • Colombini A, Corsetti R, Machado M, Graziani R, Lombardi G, Lanteri P, Banfi G. Serum creatine kinase activity and its relationship with renal function indices in professional cyclists during the Giro d’Italia 3-week stage race. Clin J Sport Med 2012;22:408–13.
  • Patil HR, O’Keefe JH, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Cardiovascular damage resulting from chronic excessive endurance exercise. Mo Med 2012;109: 312–21.
  • O’Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA, McCullough PA. Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 2012; 87:587–95.
  • Selden MA, Helzberg JH, Waeckerle JF, Browne JE, Brewer JH, Monaco ME, Tang F, O’Keefe JH. Cardiometabolic abnormalities in current National Football League players. Am J Cardiol 2009;103:969–71.
  • Selden MA, Helzberg JH, Waeckerle JF. Early cardiovascular mortality in professional football players: fact or fiction?Am J Med 2009;122:811–4.
  • Helzberg JH, Camilo J, Waeckerle JF, O’Keefe JH. Review of cardiometabolic risk factors among current professional football and professional baseball players. Phys Sportsmed 2010;38:77–83.
  • Shimano M, Ouchi N, Walsh K. Cardiokines: recent progress in elucidating the cardiac secretome. Circulation 2012;126:327–32.
  • Eggers KM, Kempf T, Wallentin L, Wollert KC, Lind L. Change in growth differentiation factor 15 concentrations over time independently predicts mortality in community-dwelling elderly individuals. Clin Chem 2013;1091–8.
  • Daniels LB, Clopton P, Laughlin GA, Maisel AS, Barrett-Connor E. Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study. Circulation 2012;123:2101–10.
  • Rohatgi A, Patel P, Das SR, Ayers CR, Khera A, Martinez-Rumayor A, Berry JD, McGuire DK, de Lemos JA. Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study. Clin Chem 2012;58:172–82.
  • Wang TJ, Wollert KC, Larson MG. Coglianese E, McCabe EL, Cheng S, Ho JE, Fradley MG, Ghorbani A, Xanthakis V, Kempf T, Benjamin EJ, Levy D, Vasan RS, Januzzi JL. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012;126:1596–604.
  • Xu X, Li Z, Gao W. Growth differentiation factor 15 in cardiovascular diseases: from bench to bedside. Biomarkers 2011;16:466–75.
  • Hohensinner PJ, Niessner A, Huber K, Weyand CM, Wojta J. Inflammation and cardiac outcome. Curr Opin Infect Dis 2011;24:259–64.
  • Bonaterra GA, Zugel S, Thogersen J, Walter SA, Haberkorn U, Strelau J, Kinscherf R. Growth differentiation factor-15 deficiency inhibits atherosclerosis progression by regulating interleukin-6-dependent inflammatory response to vascular injury. J Am Heart Assoc 2012;e002550.
  • Wang J, Pantopoulos K. Regulation of cellular iron metabolism. Biochem J 2011;434:365–81.
  • Wojtczak-Soska K, Pietrucha T, Sakowicz A, Lelonek M. Soluble ST2 protein in chronic heart failure is independent of traditional factors. Arch Med Sci 2013;9:21–6.
  • Banfi G, Dolci A. Preanalytical phase of sport biochemistry and haematology. J Sports Med Phys Fitness 2003;43: 223–30.
  • Banfi G, Colombini A, Lombardi G, Lubkowska A. Metabolic markers in sports medicine. Adv Clin Chem 2012;56:1–54.
  • Lippi G, Banfi G, Botre F, de la Torre X, De Vita F, Gomez-Cabrera MC, Maffulli N, Marchioro L, Pacifici R, Sanchis-Gomar F, Schena F, Plebani M. Laboratory medicine and sports: between Scylla and Charybdis. Clin Chem Lab Med 2012;50:1309–16.
  • Lippi G, Cervellin G, Banfi G, Plebani M. Cardiac troponins and physical exercise. It's time to make a point. Biochem Med (Zagreb) 2011;21:55–62.
  • Corsetti R, Lombardi G, Barassi A, Lanteri P, Colombini A, D’Eril GM, Banfi G.Cardiac indexes, cardiac damage biomarkers and energy expenditure in professional cyclists during the Giro d’Italia 3-weeks stage race. Biochemia Medica 2012;50:237–46.
  • Hsiao EC, Koniaris LG, Zimmers-Koniaris T, Sebald SM, Huynh TV, Lee SJ. Characterization of growth-differentiation factor 15, a transforming growth factor beta superfamily member induced following liver injury. Mol Cell Biol 2000;20:3742–51.
  • Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005;23:543–8.
  • Zimmers TA, Jin X, Hsiao EC, Perez EA, Pierce RH, Chavin KD, Koniaris LG. Growth differentiation factor-15: induction in liver injury through p53 and tumor necrosis factor-independent mechanisms. J Surg Res 2006;130:45–51.
  • Andersson J, Jansson JH, Hellsten G, Nilsson TK, Hallmans G, Boman K. Effects of heavy endurance physical exercise on inflammatory markers in non-athletes. Atherosclerosis 2010;209:601–5.
  • Lombardi G, Colombini A, Lanteri P, Banfi G. Reticulocytes in sports medicine: an update. Adv Clin Chem 2013;59: 125–53.
  • Sanchis-Gomar F, Bonaguri C, Aloe R, Pareja-Galeano H, Martinez-Bello V, Gomez-Cabrera MC, Candel J, Viña J, Lippi G. Effects of acute exercise and xanthine oxidase inhibition on novel cardiovascular biomarkers. Transl Res 2013;102–9.
  • Poledne R, Lorenzova A, Stavek P, Valenta Z, Hubácek J, Suchánek P, Pitha J. Proinflammatory status, genetics and atherosclerosis. Physiol Res 2009;58:111–8.
  • Hingorani AD, Shah T, Casas JP, Humphries SE, Talmud PJ. C-reactive protein and coronary heart disease: predictive test or therapeutic target?Clin Chem 2009;55: 239–55.
  • Corsetti R, Lombardi G, Lanteri P, Colombini A, Graziani R, Banfi G. Haematological and iron metabolism parameters in professional cyclists during the Giro d’Italia 3-weeks stage race. Clin Chem Lab Med 2012;50:949–56.
  • Lira FS, Rosa JC, Lima-Silva AE, Souza HA, Caperuto EC, Seelaender MC, Damaso AR, Oyama LM, Santos RV. Sedentary subjects have higher PAI-1 and lipoproteins levels than highly trained athletes. Diabetol Metab Syndr 2010; 2–7.
  • Pihl E, Zilmer K, Kullisaar T, Kairane C, Pulges A, Zilmer M. High-sensitive C-reactive protein level and oxidative stress-related status in former athletes in relation to traditional cardiovascular risk factors. Atherosclerosis 2003;171:321–6.
  • Naghii MR, Aref MA, Almadadi M, Hedayati M. Effect of regular physical activity on non-lipid (novel) cardiovascular risk factors. Int J Occup Med Environ Health 2011;24: 380–90.
  • Milani RV, Lavie CJ, Mehra MR. Reduction in C-reactive protein through cardiac rehabilitation and exercise training. J Am Coll Cardiol 2004;43:1056–61.
  • Demyanets S, Kaun C, Pentz R, Krychtiuk KA, Rauscher S, Pfaffenberger S, Zuckermann A, Aliabadi A, Gröger M, Maurer G, Huber K, Wojta J. Components of the interleukin-33/ST2 system are differentially expressed and regulated in human cardiac cells and in cells of the cardiac vasculature. J Mol Cell Cardiol 2013;60:16–26.
  • Bartunek J, Delrue L, Van Durme F, Muller O, Casselman F, De Wiest B, Croes R, Verstreken S, Goethals M, de Raedt H, Sarma J, Joseph L, Vanderheyden M, Weinberg EO. Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load. J Am Coll Cardiol 2008;52: 2166–74.
  • Xu J, Kimball TR, Lorenz JN, Brown DA, Bauskin AR, Klevitsky R, Hewett TE, Breit SN, Molkentin JD. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006;342–50.
  • Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol 2008;98:169–75.
  • Liu Q, Davidoff O, Niss K, Haase VH. Hypoxia- inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis. J Clin Invest 2012;122:4635–44.
  • Waalen J, von Lohneysen K, Lee P, Xu X, Friedman JS. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol 2011;87: 107–16.
  • Banfi G, D’Eril GM, Barassi A, Lippi G. N-terminal proB-type natriuretic peptide (NT-proBNP) concentrations in elite rugby players at rest and after active and passive recovery following strenuous training sessions. Clin Chem Lab Med 2008;46:247–9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.